Edaravone for the Treatment of Motor Neurone Disease: A Critical Review of Approved and Alternative Formulations against a Proposed Quality Target Product Profile

Edaravone is one of two main drugs for treating motor neurone disease (MND). This review proposes a specific quality target product profile (QTPP) for edaravone following an appraisal of the issues accounting for the poor clinical uptake of the approved IV and oral liquid edaravone formulations. Thi...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Riuna O'Neill (Author), Okhee Yoo (Author), Philip Burcham (Author), Lee Yong Lim (Author)
Format: Knjiga
Izdano: MDPI AG, 2024-07-01T00:00:00Z.
Teme:
Online dostop:Connect to this object online.
Oznake: Označite
Brez oznak, prvi označite!

Internet

Connect to this object online.

3rd Floor Main Library

Podrobnosti zaloge 3rd Floor Main Library
Signatura: A1234.567
Kopija 1 Prosto